EOS imaging received approval from the China Food and Drug Administration to market the EOS orthopaedic imaging system in China.
The clearance falls in line with the company’s strategy to expand in North America, the EU, Middle East and Asia Pacific. EOS cites >1,200 top grade (3A and 3B) hospitals in China within an already-established distribution partnership.
Source: EOS imaging
Other global initiatives in support of EOS’ technology include:
- Co-promotion agreement with Stryker for U.K. market
- CE Mark for spineEOS Online 3D surgical planning app
- Innovative Technology Status achieved in Korea
EOS imaging received approval from the China Food and Drug Administration to market the EOS orthopaedic imaging system in China.
The clearance falls in line with the company's strategy to expand in North America, the EU, Middle East and Asia Pacific. EOS cites >1,200 top grade (3A and 3B) hospitals in China within an already-established...
EOS imaging received approval from the China Food and Drug Administration to market the EOS orthopaedic imaging system in China.
The clearance falls in line with the company’s strategy to expand in North America, the EU, Middle East and Asia Pacific. EOS cites >1,200 top grade (3A and 3B) hospitals in China within an already-established distribution partnership.
Source: EOS imaging
Other global initiatives in support of EOS’ technology include:
- Co-promotion agreement with Stryker for U.K. market
- CE Mark for spineEOS Online 3D surgical planning app
- Innovative Technology Status achieved in Korea
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.